Drug Shortage Report for GLUCONORM 1.0MG
| Report ID | 98703 |
| Drug Identification Number | 02239925 |
| Brand name | GLUCONORM 1.0MG |
| Common or Proper name | Repaglinide |
| Company Name | NOVO NORDISK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | REPAGLINIDE |
| Strength(s) | 1.0MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 90 |
| ATC code | A10BX |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2019-11-15 |
| Actual start date | |
| Estimated end date | 2019-12-06 |
| Actual end date | 2019-11-29 |
| Shortage status | Resolved |
| Updated date | 2019-11-30 |
| Company comments | 1-800-465-4334 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 101-2476 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 6M1 |
| Company contact information | 1 800 465 4334 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2019-11-30 | English | Compare |
| v7 | 2019-11-29 | French | Compare |
| v6 | 2019-11-29 | English | Compare |
| v5 | 2019-11-18 | French | Compare |
| v4 | 2019-11-18 | English | Compare |
| v3 | 2019-11-16 | English | Compare |
| v2 | 2019-11-14 | French | Compare |
| v1 | 2019-11-14 | English | Compare |
Showing 1 to 8 of 8